| Pharmaceutical Information |
| Drug Name |
Alteplase |
| Drug ID |
BADD_D00087 |
| Description |
Human tissue plasminogen activator, purified, glycosylated, 527 residues purified from CHO cells |
| Indications and Usage |
For management of acute myocardial infarction, acute ischemic strok and for lysis of acute pulmonary emboli |
| Marketing Status |
Prescription |
| ATC Code |
B01AD02; S01XA13 |
| DrugBank ID |
DB00009
|
| KEGG ID |
D02837
|
| MeSH ID |
D010959
|
| PubChem ID |
22976653
|
| TTD Drug ID |
D07BQE
|
| NDC Product Code |
50242-041; 63552-041; 50242-044; 50242-085 |
| Synonyms |
Tissue Plasminogen Activator | Plasminogen Activator, Tissue | Tissue Activator D-44 | Tissue Activator D 44 | Tisokinase | Tissue-Type Plasminogen Activator | Tissue Type Plasminogen Activator | TTPA | T-Plasminogen Activator | T Plasminogen Activator | Alteplase | Plasminogen Activator, Tissue-Type | Plasminogen Activator, Tissue Type | Activase | Actilyse | Lysatec rt-PA | Lysatec rt PA | Lysatec rtPA |
|
| Chemical Information |
| Molecular Formula |
C42H36N2 |
| CAS Registry Number |
177799-16-5 |
| SMILES |
CC1=CC=C(C=C1)N(C2=CC=C(C=C2)C)C3=C4C=CC=CC4=C(C5=CC=CC=C53)N(C6=CC=C(C=C6)C)C7=
CC=C(C=C7)C |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
